Your browser doesn't support javascript.
loading
Adapting Lot Quality Assurance Sampling to accommodate imperfect diagnostic tests: application to COVID-19 serosurveillance in Haiti.
Fulcher, Isabel R; Clisbee, Mary; Lambert, Wesler; Leandre, Fernet Renand; Hedt-Gauthier, Bethany.
Affiliation
  • Fulcher IR; Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Ave, Boston, MA, USA. isabel_fulcher@hms.harvard.edu.
  • Clisbee M; Department of Research, Zanmi Lasante, Santo 18A, Croix-des-Bouquets, Haïti.
  • Lambert W; Department of Research, Education and Strategic Information, Santo 18A, Croix-des-Bouquets, Haïti.
  • Leandre FR; Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Ave, Boston, MA, USA.
  • Hedt-Gauthier B; Division of Global Health Equity, Brigham and Women's Hospital, 800 Boylston Street Suite 300, Boston, USA.
BMC Public Health ; 22(1): 2221, 2022 11 29.
Article in En | MEDLINE | ID: mdl-36447195
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lot Quality Assurance Sampling / COVID-19 Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Caribe / Haiti Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lot Quality Assurance Sampling / COVID-19 Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Caribe / Haiti Language: En Year: 2022 Type: Article